Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Journal of Ovarian Research|October 10, 2014
The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancerMasaaki Takai, Yoshito Terai, Hiroshi Kawaguchi, et al.
Journal of Clinical Medicine|December 23, 2022
The Effect of Maternal Coagulation Parameters on Fetal Acidemia in Placental AbruptionAtsuko Sugimoto, Tomohito Tanaka, Keisuke Ashihara, et al.
Cancers|June 24, 2022
Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic CharacterizationShunsuke Miyamoto, Tomohito Tanaka, Kensuke Hirosuna, et al.
Journal of Ovarian Research|April 10, 2014
Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancerHiroshi Kawaguchi, Yoshito Terai, Akiko Tanabe, et al.
Journal of Ovarian Research|September 1, 2018
A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratomaKazuya Maeda, Yoshito Terai, Shinichi Terada, et al.
International Journal of Clinical Oncology|September 30, 2025
Lymph node metastasis risk in submucosal invasive gastric cancer based on C-reactive protein gene polymorphism analysisKotaro Honda, Kohei Taniguchi, Kazumasa Komura, et al.
Oncology Reports|September 10, 2015
CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancerTomohito Tanaka, Yoshito Terai, Yuhei Kogata, et al.
Journal of Clinical Medicine|May 14, 2022
Endometrial Cancer Patient-Derived Xenograft Models: A Systematic ReviewTomohito Tanaka, Ruri Nishie, Shoko Ueda, et al.
International Journal of Molecular Sciences|September 10, 2021
Patient-Derived Xenograft Models in Cervical Cancer: A Systematic ReviewTomohito Tanaka, Ruri Nishie, Shoko Ueda, et al.
Pageof 11